-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on BioNTech, Lowers Price Target to $120

Benzinga·10/23/2025 16:05:44
Listen to the news
JP Morgan analyst Jessica Fye maintains BioNTech (NASDAQ:BNTX) with a Neutral and lowers the price target from $121 to $120.